The Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved. The FDA reviews the IND application for safety to assure that research subjects will not be subjected to unreasonable risk. If the application is cleared, the candidate drug usually enters a Phase 1 clinical trial.
Related Journals of Investigational New Drug
International journal of drug development and Research, Journal of Drug Abuse, Molecular Enzymology and drug tragets, Food and Drug Law Journal, Indian Drugs, Infection and Drug Resistance, Infectious Disorders- Drug Targets, Inflammation and Allergy- Drug Targets, International Drug Discovery
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2017 All rights reserved. iMedPub Last revised : December 10, 2017